News & Events
FDA approves new non-invasive methods for diagnosing sexually transmitted diseases
- May 31, 2019
- Posted by: Wiley M. Wagner
- Category: Science
Sexually transmitted diseases and sexually transmitted infections are a real scourge of modern society – especially in the USA, where more and more scientists are trying to cope with this. And today it became known that a team of venereologists from several US universities attempted to create a new type of diagnostic tests to determine such infections in a non-invasive way. Because it is this way that is the most promising and interesting, and also less unpleasant for most users – and the results of the new experiment really prove it.
The new diagnostic tests are called Aptima Combo 2 and Xpert CT / NG and both are a fairly standard smear of saliva and mucous membranes of the mouth and rectum – thus, it becomes clear that taking such tests becomes much easier than traditional colorectal or urinal ones. Nevertheless, the developers say that these new diagnostic tools must first be tested in the environment of the Federal Food and Drug Administration of the United States, whose members should carefully examine the presented diagnostic medicine tools.
According to preliminary information about the first stages of laboratory testing of these instruments, scientists report that they have not only faster sample removal, but also deliver significantly less discomfort for end patients – and this is the main charm of non-invasive diagnostic methods of modern medicine.
Nevertheless, it is worth noting the fact that genital infections often have hidden or deceptive symptoms – for example, some types of gonorrhea. Therefore, scientists are also interested in conducting statistical studies aimed at improving the functionality and capabilities of their new non-invasive tests, which may be a really important point.